TMR Research

Wednesday, 14 June 2017

Advanced Visualization Systems Market Worldwide Industry Volume By Region 2016 - 2024

Global advanced (3D/4D) visualization systems market is segmented according to major types of platform, which include: ultrasound AVS, Magnetic Resonance Imaging AVS, Computed Tomography AVS, Positron Emission Tomography AVS and others (radiotherapy AVS, nuclear medicine AVS, etc.). The market has been further studied from the point of view of major applications of advanced (3D/4D) visualization systems. The market on the basis of application has been categorized into cardiology, oncology, neurology and others (orthopedics, gastrointestinal, gynecology, etc.). The market has also been segmented on the basis of end-user into three segments, viz., hospitals, diagnostic laboratories and academics & research.

The report on the global advanced (3D/4D) visualization systems analyses the current and future prospects of the market for the software and application products. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

Obtain Report Details @

http://www.transparencymarketresearch.com/advanced-3d-4d-visualization-systems.html

The research is a robust combination of primary and secondary research. Primary research forms the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global advanced (3D/4D) visualization systems market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, and Porter’s Five Forces analysis providing a thorough analysis of the overall competitive scenario in the global advanced (3D/4D) visualization systems market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation and growing number of acute and chronic patient in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Additionally, the report contains market attractiveness analysis by geography and competitive landscape by key players. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market. The report also provides an extensive event impact analysis which gives an insight into major events and their effects on the market in positive and negative sense. The analysis also provides a list of recently launched products.

Geographically, the global advanced visualization systems market has been segmented into five regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In addition the regions have been further segmented by major countries from each region, which include the U.S, Canada, U.K., Germany, Japan, China, Brazil, Mexico, and South Africa. The report also profiles major players in the advanced (3D/4D) visualization systems market based on various attributes such as company overview, financial overview, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Carestream Health, Inc., CONMED Corporation, Fujifilm Holding America Corporation, GE Healthcare, Intelerad Medical Systems Incorporated, Philips Healthcare, QI Imaging, LLC, Siemens Healthcare, Terarecon, Inc., Toshiba Medical Systems Corporation, Visage Imaging and Visualization Sciences Group.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2547

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Ultraviolet Germicidal Irradiation Market - Worldwide Industry Volume and Region Analysis - 2023

The ultraviolet germicidal irradiation market report evaluates each of the segments and sub-segments in detail for market trends, recent developments, outlook, and opportunities. The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that currently have strong impact on the global ultraviolet germicidal irradiation market and could influence the market in future. The global market for ultraviolet germicidal marker comprises of air disinfectant and surface disinfectant. Growth of the market is attributed to increased prevalence of infectious disorders and airborne diseases, rising incidence of hospital-acquired infections, and growing hygiene consciousness across the globe. The global ultraviolet germicidal irradiation market has been experiencing steady growth. The trend is expected to continue during the forecast period from 2015 to 2023.

Obtain Report Details @
http://www.transparencymarketresearch.com/ultraviolet-germicidal-irradiation-market.html

Based on type, the ultraviolet germicidal irradiation market has been segmented into air disinfectant and surface disinfectant. The air disinfectant segment has been further divided into in-duct air disinfection, recirculation units, upper room systems, and others (UV barrier system and overhead tank disinfection). The surface disinfectant segment has been categorized into area/room disinfection, equipment & packaging disinfection, lower room disinfection, and others. The market for ultraviolet germicidal irradiation are being developed because of increasing adoption and growth installation of UV germicidal lamps and other devices in U.S. in the past few years. The air disinfectant segment is likely to witness the fastest growth due to easy usage of UV germicidal lamps and low cost of installation and maintenance. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023.

Additional information such as recent developments in ultraviolet germicidal irradiation, market dynamics, and value chain analysis, provided in the market overview chapter would assist new and existing players to venture and explore latent market opportunities in impending years. The stakeholders of this report include companies involved in research and development and applications for UV germicidal irradiation. In order to provide a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends, and competition for different regions.

Heat map analysis has been provided in the market overview section to explain the intensity of competition between leading market players operating across the globe. This will help market players to take strategic decisions in order to strengthen their market positions and increase their market shares. The recommendations section included in the report assist the existing market players involved in the manufacture of UV germicidal irradiation products in targeting the emerging economies. The report also profiles major players in the global ultraviolet germicidal irradiation market based on various attributes such as company details, business overview, financial facts, business strategies and recent developments.

Major drivers likely to boost demand for and growth of ultraviolet germicidal irradiation products include increase in the incidence of hospital acquired infections and technological innovations. Apart from this, favorable regulatory scenario would assist in fueling market growth. The challenges for market growth include high installation and maintenance cost. However, the report also highlights various opportunities that are expected to boost market growth during the forecast period.

The report includes the major key players in the ultraviolet germicidal irradiation (UVGI) market include American Ultraviolet, Atlantic Ultraviolet Corporation, General Electric, Halma plc (Aquionics), Philips, and UltraViolet Devices, Inc.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10826

About Us

Tuesday, 13 June 2017

Dental Laboratories Market - Worldwide Industry Volume and Region Analysis - 2024

Global Dental Laboratories Market: Overview

The global market for dental laboratories is undergoing a widespread transformation. The rising prevalence of oral disorders, coupled with the growing awareness regarding oral care and hygiene, is driving this market substantially. In addition to this, the increase in cosmetic surgeries of teeth, fueled by the surging interest of consumers towards personality grooming, is expected to support this market considerably over the forecast period.

According to Transparency Market Research (TMR), the global market for dental laboratories stood at US$12.9 bn in 2014. Rising at a CAGR of 4.90% during the period from 2015 to 2023, the market is likely to reach US$20.2 bn by the end of 2023.

In this research report, the worldwide market for dental laboratories has been studied with a microscopic view in an attempts to provide a detailed market assessment on the basis of its past performance and its present status. The recent prominent trends and the lucrative growth opportunities within this market have also been examined thoroughly to identify its future status in this research study.

Obtain Report Details @
http://www.transparencymarketresearch.com/dental-laboratories-market.html

Global Dental Laboratories Market: Trends and Opportunities

The rise in the aesthetic consciousness of consumers across the world is having a significant influence on the global market for dental laboratories. The substantial rise in the disposable income of people has boosted their spending power, fueling their interest in facial beauty, especially in their dental care. This, as a result, is adding considerably to the worldwide dental laboratories market.

Global Dental Laboratories Market: Geographical Analysis

On the basis of geography, the global market for dental laboratories is spread across North America, Asia Pacific, Europe, and the Rest of the World. The U.S. and Canada are the key domestic markets for dental laboratories in North America. The Europe market for dental laboratories stretches across Italy, the U.K., France, Germany, Spain, and the Rest of Europe. Japan, China, and the Rest of Asia Pacific drives the Asia Pacific market while Latin America and the Middle East and Africa are the main regional markets in the Rest of the World.

Europe has acquired the leading position in this market and is closely followed by North America. The increasing number of community-based oral health programs, conducted across Europe, which focus on delivering preventive treatments, increasing awareness, and improving patient education about various dental procedures and artificial products, has contributed significantly to the growth of the Europe market for dental laboratories. Researchers expect this regional market to remain on top over the next few years.

Asia Pacific, on the other hand, is expected to present attractive growth opportunities to market players in the years to come. The increasing trend of dental tourism and the substantial surge in the export demand for periodontics, orthodontic, bridges, crowns, and implants in emerging economies, such as India and China, are projected to propel the Asia Pacific dental laboratories market in the next few years.

Companies Mentioned in the Research Report

Sirona Dental Systems, Henry Schein Inc., Patterson Companies Inc., 3M Health Care, Keating Dental Arts, Modern Dental Laboratory Co. Ltd., Institut Straumann AG, Shofu Inc., National Dentex Corp., Danaher Corp., Yenadent Ltd. Sti., Dentcare Dental Lab, and Zimmer Biomet Holdings Inc. are some of the leading players in the global market for dental laboratories.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2320

About Us

Worldwide Uterine Fibroid Diagnostics and Therapeutics Market Share by Industry Research 2016 - 2024

The market for uterine fibroid diagnostics and therapeutics is expected to grow at a significant CAGR during 2014 to 2020. This growth is primarily driven by increasing number of women of reproductive age (WRA) across the globe. According to the Centers for Disease Control and Prevention (CDC), approximately 60 million WRA were reported in 2012 and this number is expected to rise with increasing number of women globally. According to the World Data Book, total population of women was around 3,439.4 million in 2011 and this number is expected to grow due to improving education systems mainly in developing countries such as India and China. Other factors that are also supporting the growth of uterine fibroid diagnostics and therapeutics market are rising prevalence of uterine fibroids and change in lifestyle mainly dietary pattern. Low intake of fruits and green vegetables increases the risk for developing uterine fibroids.

Uterine fibroid is a type of tumor that arises from the smooth muscle tissues of uterus. Common non-cancerous growths that develop in the muscular wall of the uterus, they are also known as leiomyoma (benign tumor), fibroleiomyoma, fibromyoma and myoma. They vary in size from tiny to larger than a cantaloupe. Sometimes, they led the uterus to grow to the size of a five-month pregnancy. Fibroids presence usually is multiple is number and if its number is uncountable, it is referred to as uterine leiomyomatosis. Fibroids are amongst the most common form of benign tumors and usually affect the females during the middle of reproductive age and later reproductive age. The malignant form of fibroid, known as leiomyosarcoma, is very uncommon.

Obtain Report Details @
http://www.transparencymarketresearch.com/uterine-fibroid-diagnostics-therapeutics-market.html

Uterine fibroids are usually asymptomatic, however once they start growing, they create various problems such as painful and heavy menstruation, affecting urine urgency and frequency, and painful sexual intercourse. It sometimes, may also interfere with pregnancy and dramatically increase in size during pregnancy. It is thought to be because of increase in levels of estrogen during pregnancy. It does not affect the women post menopause as the level of estrogen that circulates in the blood, reduces drastically. However, women who are taking estrogen supplement in hormone replacement therapy are expected to experience the symptoms disease.

Uterine fibroids are of various types namely subserosal fibroids, intramural fibroids and submucosal fibroids. Subserosal fibroids develop under the uterus outside covering and expand outward through uterine wall and result in knobby appearance of the uterus. Intramural fibroids develop into the lining of the uterus and hence, expand inward resulting in increase in the size of uterus. Amongst all, it is the most common uterine fibroids. Submucosal fibroids develop under the uterus linings and it causes various medical conditions such as heavy bleeding and prolonged menstruation. It is rarest of all uterus fibroids.

Uterine fibroids can be diagnosed using various imaging modalities such as medical resonance imaging (MRI) scanners, computed tomography (CT) scanners and ultrasound devices. Amongst all, ultrasound devices are used extensively for diagnosing uterine fibroids owing to its efficiency and popularity for gynecological purpose. Also, it does not produce any harmful rays that may harm the fetus (if women suffering from uterine fibroids is pregnant), increasing its preference among radiologist. Other diagnosing procedures include hysterosonography, hysterosalpingography and hysteroscopy.

Various treatment procedures have been adopted by physicians to cure the disease that include nonsurgical uterine fibroid embolization, magnetic resonance guided focused ultrasound, myolysis, endometrial ablation and resection of submucosal fibroids, hysterectomy and myomectomy surgery. Among all the aforementioned treatment procedures, nonsurgical uterine fibroid embolization is the most extensive used method of treatment. Various medications are also advised to the patients suffering from uterine fibroids that include gonadotropin-releasing hormone agonists, progestin-releasing intrauterin, progestins or oral contraceptives and nonsteroidal anti-inflammatory drugs.

Uterine Fibroid Diagnostics and Therapeutics Market Key Players

The major players operating in the uterine fibroid diagnostics and therapeutics market include Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company and Siemens Healthcare among other significant players.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14963

About Us

Worldwide Angiosarcomas Treatment Market Trends & Industry Forecast by 2016 - 2024

Rare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, such as bone, breast, skin, fats and soft tissues. One such rare type of soft tissue tumor is called as Angiosarcomas. This tumor begins to grow in the cells of a blood vessels and can occur in any part of body. Angiosarcoma tumors involve rapidly proliferating cancerous cells originated from endothelial or mesenchymal sources and develop blood filled channels. Angiosarcoma harbors is the worst prognosis among all sarcoma subtypes.

Obtain Report Details @
http://www.transparencymarketresearch.com/angiosarcomas-treatment-market.html

Angiosarcomas treatment market classification

Depending on the instigation of tumor, Angiosarcomas are classified as hemagiosarcoma (begin in blood vessels) and lymphangiosarcome (tumor begins in lymph vessels). The major causes of the disease are unknown, however, lymphederma is considered as a key propeller of the disease condition. In addition to this, frequent and long term exposure of the radiation is also considered as an important cause.

The major symptoms include skin infections; however, the deeply situated tumors may not show any distinct symptom of the disease. The latter condition worsens the situation and may be a fatal one. The diagnostic procedures mainly include CT, MRI and PET scan. In addition, biopsy procedure has proved its effectiveness in the disease diagnosis. This disease has a very low incidence rate of 2-3 per million people and also occurs in patients of breast cancer who have undergone radiation therapy.

Angiosarcomas treatment market remedies

Angiosarcoma treatment requires medical attention from a multidisciplinary medical team and includes oncologists, surgeons and other medical team. The disease is treated primarily with surgical intervention. Chemotherapy is also used due to high risk of local relapse and distant metastatic disease. However, chemotherapy and radiation therapy are critical for treating Angiosarcomas before and after surgery. The most common chemotherapeutic drug for treating Angiosarcomas includes doxorubicin. However, combination therapy involving mesna, doxorubicin, and ifosfamide has also shown effectiveness against Angiosarcomas. There have been several attempts in last decade to develop drugs that target blood vessels growth stimulator VEGF and thereby cause shrinking of angiosarcomas. These drugs include bevacizumab, irinotecan, sildenafil, SU11248, BAY43-9006, and AMG706. Radiation therapy includes exposure of high power gamma and X-rays to irradiate the tumors.

Angiosarcomas treatment market research

In a recent research at University of North Carolina, researcher reported a monoclonal antibody targeted towards a protein known as SFRP2 found to inhibit growth of angiosarcoma. The study was initiated because SFRP2 acts as a potent stimulator of angiogenesis and it was therefore hypothesized that targeting SFRP2 could inhibit tumor growth. The study is still in very nascent stage and will enter into clinical trials provided the researchers obtain enough funding for their research. The major drivers of the market include steadily increasing prevalence of the disease. Although the disease is considered as rare (less than 1 percent of the sarcoma diagnosed population), the prevalence is increasing steadily. This is anticipated to drive the market during forecast period 2014 – 2020. In addition, extensive R&D practices also fuels the market growth. A number of drugs, such as, AMG-386, sildenafil, and many others are under pipeline studies and expected to enter in the market in coming 5-10 years. A major restraint in developing specific drug for treating Angiosarcomas is the limited number of people on which the drug can be tested to confirm its safety and efficacy. Angiosarcomas are so rare accounting for only 1% of sarcomas which in turn account for only 1 percent of all kinds of cancer.

The major players operating in the global Angiosarcomas market include Pfizer, Inc., Genentech, Inc., Bayer Healthcare, Janssen Products, LP, Sanofi S.A., and Amgen, Inc.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14942

About Us

Worldwide Demyelinating Diseases Therapeutics Market Share by Industry Research 2016 - 2024

Demyelinating diseases are those diseases which affect the nervous system mostly damaging the myelin sheath of neurones. Thus, causing distortion of signals in the affected nerves which further leads to the deficiency in sensation, cognition, movements or impairing of any other physical function carried out by the affected nerve. In addition, demyelinating diseases are classified into two types demyelinating leukodystrophic diseases and demyelinating myelinoclastic diseases. Demyelinating diseases may occur due to genetics irregularities, by infectious agents and by autoimmune reactions, though, at times, the cause may remain unknown. At times demyelination is caused by neuroleptics or extreme exposure to chemical agents.

The symptoms that are present in demyelinating diseases may differ from patient to patient. However, few of the common symptoms may include blurred double vision, ataxia, dysarthria, impaired muscle coordination, loss of sensation, hand paralysis and speech and hearing disorders.

Few of the guiding principles set for treating a person suffering from any of the demyelinating diseases include improving the patient's living environment and lifestyle, counselling, physical exercise and relaxation. A holistic treatment approach is considered more appropriate in such conditions.

Obtain Report Details @
http://www.transparencymarketresearch.com/demyelinating-diseases-therapeutics-market.html

The Demand for Demyelinating Diseases Therapeutics Market Expected to Gain Traction in the Coming Years

There are several demyelinating diseases caused due to the breakdown of nervous system. Higher prevalence of such incidences in the recent years is expected to favor the global demyelinating diseases therapeutics market. In other words, demyelinating diseases are often linked with disorders in the human nervous system, which is a part of neurology. Other factors expected to drive the global demyelinating diseases therapeutics market include changing lifestyle and diminishing quality of leaving the environment.

On the other hand, limited options of treatment available for treatment of demyelinating diseases remains the major concern for most players in the market. In addition, most contemporary demyelinating diseases drugs and therapies available in the market do not promise complete cure of such disorders. Moreover, the high-cost and low credibility of the latest drugs are other factors expected to negatively impact the overall market.

The ongoing research and development programs for improving the current durgs used for the treatment of demyelinating diseases are considered as a good news for the market. In addition, novel drugs in R&D pipeline is expected to favor the global demyelinating diseases in the near future. For instance, the recent introduction of monoclonal antibodies (MAbs) is a major factor considered to influence the market growth. These latest drugs are promising higher efficacy compare to current therapies.

Regional Segmentation

On the basis of region, the global demyelinating diseases therapeutics market has been segmented into six key regions namely North America, Western Europe, Eastern Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa (MEA). North America is considered as one of the major markets for demyelinating diseases therapeutics attributed to the rising number cases of demyelinating diseases in the region. In addition, the occurrence of demyelinating diseases in the U.S has grown significantly over the years leading to a higher demand for its treatment. Further, availability of advanced therapeutics and drugs is supplementing the growth of demyelinating diseases therapeutics market in the region. The European market is also expected to witness a healthy growth of the market owing to rising number of incidence, especially in countries such the U.K., Germany and Spain.

Key Players

Few of the key players identified in the global demyelinating diseases therapeutics market include Teva Pharmaceutical Industries Ltd., Baxalta, Geneuro Sa, and Pfizer Inc.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14795

About Us

Patient Warming Devices Market - Worldwide Industry Analysis and Forecast 2016 - 2024

Global Patient Warming Devices Market: Overview

This report on the patient warming devices market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various patient warming devices such as surface warming devices as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global market with respect to the leading market segments based on major products, applications and geographies.

Obtain Report Details @
http://www.transparencymarketresearch.com/patient-warming-devices-market.html

Global Patient Warming Devices Market: Key Segments

The global patient warming devices market has been studied based on major product/device segments, application segments, and their regional as well as national markets. Based on product type, the global market has been categorized into three major segments: surface warming systems, intravascular warming systems, and patient warming accessories. Based on applications, the market has been categorized into four major segments: acute care, perioperative care, new born care, and others. Based on end user, the market has been categorized into four major segments: hospitals, clinics, nursing facilities and others. The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

Global Patient Warming Devices Market: Scope of the Report

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the patient warming devices market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. Porter’s five forces analysis is also provided in this section to understand the market considering the different parameters that have an impact on the sustainability of the companies operating in the market. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Global Patient Warming Devices Market: Regional Outlook

Geographically, the global market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). Each regional market for patient warming devices has been further categorized into major national markets such as the U.S, Canada, Germany, France, the U.K., Japan, China, India and Brazil. Market revenue in terms of USD million for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

Companies Mentioned in the Report

The recommendations section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global market. The report also profiles major players in the patient warming devices market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. The key players operating in the global market are 3M Health Care, ZOLL Medical Corporation, C. R. Bard, Inc., Smiths Medical, Stryker Corporation, Medtronic plc, GE Healthcare, Inspiration Healthcare (INDITHERM), and Philips Healthcare among others.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7877

About Us